Literature DB >> 10410987

Role of cytokines in epidermal Langerhans cell migration.

B Wang1, P Amerio, D N Sauder.   

Abstract

In the epidermal compartment of skin, keratinocytes (KC), Langerhans cells (LC), and their soluble products, i.e. cytokines, constitute a unique immunologic microenvironment. KC participate in cutaneous immune responses by producing various cytokines. LC, a member of the dendritic cell (DC) family, represent the professional antigen-presenting cells in the epidermis. Although it has been demonstrated that migration of LC from skin to lymph nodes is a critical step for the antigen presentation, molecular mechanisms for such an event remain unclear. Recent studies suggest that cytokines are able to modulate LC/DC migration. There is accumulating evidence that proinflammatory cytokines including interleukin (IL)-1 and tumor necrosis factor alpha promote LC emigration from the skin, whereas the anti-inflammatory cytokine IL-10 is a counter-regulator. LC/DC express chemokine receptors. Chemokines generated from lymphatic endothelial cells and lymph node cells play a role in the directional migration of LC/DC into lymph nodes. This article reviews current studies on the role of cytokines in LC/DC migration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10410987     DOI: 10.1002/jlb.66.1.33

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  36 in total

Review 1.  Cell-mediated immune response to human papillomavirus infection.

Authors:  M Scott; M Nakagawa; A B Moscicki
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  Major histocompatibility complex class II- fetal skin dendritic cells are potent accessory cells of polyclonal T-cell responses.

Authors:  A Elbe-Bürger; A M Mommaas; E E Prieschl; E Fiebiger; T Baumruker; G Stingl
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

3.  Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells.

Authors:  Samantha Jilek; Michael Ulrich; Hans P Merkle; Elke Walter
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

4.  PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity.

Authors:  Victor Peña-Cruz; Sean M McDonough; Felipe Diaz-Griffero; Christopher P Crum; Ruben D Carrasco; Gordon J Freeman
Journal:  J Invest Dermatol       Date:  2010-05-06       Impact factor: 8.551

5.  Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis.

Authors:  Philippe Azam; Ananthakrishnan Sankaranarayanan; Daniel Homerick; Stephen Griffey; Heike Wulff
Journal:  J Invest Dermatol       Date:  2007-02-01       Impact factor: 8.551

6.  Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse.

Authors:  Nadira Durakovic; Vedran Radojcic; Mario Skarica; Karl B Bezak; Jonathan D Powell; Ephraim J Fuchs; Leo Luznik
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

Review 7.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

8.  The haemopoietic growth factor, Flt3L, alters the immune response induced by transcutaneous immunization.

Authors:  Maria E Baca-Estrada; Catherine Ewen; Donna Mahony; Lorne A Babiuk; Darryl Wilkie; Marianna Foldvari
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

9.  Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein.

Authors:  Joanna Laurson; Sadaf Khan; Rachel Chung; Karen Cross; Kenneth Raj
Journal:  Carcinogenesis       Date:  2010-02-01       Impact factor: 4.944

10.  Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines.

Authors:  Marc Pearton; Sang-Moo Kang; Jae-Min Song; Alexander V Anstey; Matthew Ivory; Richard W Compans; James C Birchall
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.